Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30307% above fair value
$63.26+1.90 (+3.10%)
Close on Nov 18, 2026Market cap $9.81BP/E –Yield –
Bruker gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Bruker's gross profit for the twelve months ending Jun 30, 2026 was $1.62B, down 2.2% year over year. For fiscal 2025 it was $1.58B, down 4.4% from the year before. Over ten years it grew 8.3% a year on average. The highest annual figure on record is $1.65B in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58B | -4.4% |
| FY2024 | Dec 31, 2024 | $1.65B | +9.0% |
| FY2023 | Dec 31, 2023 | $1.51B | +15.9% |
| FY2022 | Dec 31, 2022 | $1.31B | +7.9% |
| FY2021 | Dec 31, 2021 | $1.21B | +28.7% |
| FY2020 | Dec 31, 2020 | $939.80M | -5.6% |
| FY2019 | Dec 31, 2019 | $995.30M | +10.6% |
| FY2018 | Dec 31, 2018 | $900.00M | +10.3% |
| FY2017 | Dec 31, 2017 | $816.00M | +9.5% |
| FY2016 | Dec 31, 2016 | $745.30M | +5.2% |
| FY2015 | Dec 31, 2015 | $708.60M | -7.2% |
| FY2014 | Dec 31, 2014 | $763.30M | -5.2% |
| FY2013 | Dec 31, 2013 | $805.20M | -2.9% |
| FY2012 | Dec 31, 2012 | $829.40M | +10.2% |
| FY2011 | Dec 31, 2011 | $752.50M | +24.6% |
| FY2010 | Dec 31, 2010 | $604.00M | +16.7% |
| FY2009 | Dec 31, 2009 | $517.50M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $416.00M | +16.2% |
| Q1 FY2026 | Mar 31, 2026 | $379.80M | -2.9% |
| Q4 FY2025 | Dec 31, 2025 | $449.20M | -8.9% |
| Q3 FY2025 | Sep 30, 2025 | $379.40M | -9.4% |
| Q2 FY2025 | Jun 30, 2025 | $357.90M | -6.9% |
| Q1 FY2025 | Mar 31, 2025 | $391.20M | +10.9% |
| Q4 FY2024 | Dec 31, 2024 | $493.30M | +14.6% |
| Q3 FY2024 | Sep 30, 2024 | $418.80M | +9.4% |
| Q2 FY2024 | Jun 30, 2024 | $384.60M | +13.0% |
| Q1 FY2024 | Mar 31, 2024 | $352.80M | -1.9% |
| Q4 FY2023 | Dec 31, 2023 | $430.30M | +17.6% |
| Q3 FY2023 | Sep 30, 2023 | $382.80M | +14.2% |
| Q2 FY2023 | Jun 30, 2023 | $340.50M | +14.2% |
| Q1 FY2023 | Mar 31, 2023 | $359.70M | +17.4% |
| Q4 FY2022 | Dec 31, 2022 | $365.90M | +7.1% |
| Q3 FY2022 | Sep 30, 2022 | $335.30M | +8.6% |
| Q2 FY2022 | Jun 30, 2022 | $298.20M | +6.3% |
| Q1 FY2022 | Mar 31, 2022 | $306.30M | +9.9% |
| Q4 FY2021 | Dec 31, 2021 | $341.60M | +9.1% |
| Q3 FY2021 | Sep 30, 2021 | $308.70M | +24.3% |
| Q2 FY2021 | Jun 30, 2021 | $280.60M | +50.7% |
| Q1 FY2021 | Mar 31, 2021 | $278.70M | +44.9% |
| Q4 FY2020 | Dec 31, 2020 | $313.00M | +5.6% |
| Q3 FY2020 | Sep 30, 2020 | $248.30M | -2.2% |
| Q2 FY2020 | Jun 30, 2020 | $186.20M | -19.2% |
| Q1 FY2020 | Mar 31, 2020 | $192.30M | -10.4% |
| Q4 FY2019 | Dec 31, 2019 | $296.30M | +8.6% |
| Q3 FY2019 | Sep 30, 2019 | $253.90M | +14.1% |
| Q2 FY2019 | Jun 30, 2019 | $230.40M | +12.3% |
| Q1 FY2019 | Mar 31, 2019 | $214.70M | +7.7% |
| Q4 FY2018 | Dec 31, 2018 | $272.80M | +6.5% |
| Q3 FY2018 | Sep 30, 2018 | $222.60M | +11.9% |
| Q2 FY2018 | Jun 30, 2018 | $205.20M | +11.2% |
| Q1 FY2018 | Mar 31, 2018 | $199.40M | +13.0% |
| Q4 FY2017 | Dec 31, 2017 | $256.20M | +16.2% |
| Q3 FY2017 | Sep 30, 2017 | $198.90M | +7.4% |
| Q2 FY2017 | Jun 30, 2017 | $184.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $176.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $220.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $185.20M | – |
See a number that looks wrong?